Stock GHRS GH RESEARCH PLC
Add to a list
To use this feature you must be a member
Log inSign up

Calendar GH Research PLC

Equities

GHRS

IE000GID8VI0

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
12.6 USD -1.02% Intraday chart for GH Research PLC -1.64% +117.24%
May. 03 GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 01 JMP Securities Cuts Price Target on GH Research to $39 From $50, Maintains Market Outperform Rating MT

Chart calendar GH Research PLC

80f422c29ec60925516d.E1m9ZD_iFDr-2C2Ptabc-C3rr8ksDaJ71lmd0kCRJsE.ShHlV2iodki6u0y70P7ryx-OlpsYa5A5pmH6qyPmdLhCaowdRr1zYNOXdA~7d8ae05a6cb0db006cb88bc2dc5a5ba7

Upcoming events on GH Research PLC

2024-08-20 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)

Past events on GH Research PLC

2024-05-03 07:00 am Q1 2024 Earnings Release
2024-02-29 07:00 am Q4 2023 Earnings Release
2023-11-09 04:45 pm Q3 2023 Earnings Release
2023-08-23 07:00 am Q2 2023 Earnings Release
2023-05-11 07:30 am Q1 2023 Earnings Release
2023-03-02 07:00 am Q4 2022 Earnings Release
2022-11-10 07:05 am Q3 2022 Earnings Release
2022-09-22 10:00 am Annual General Meeting
2022-08-23 07:00 am Interim 2022 Earnings Release
2022-05-18 07:00 am Q1 2022 Earnings Release
2022-03-28 07:04 am FY 2021 Earnings Release
2021-12-06 07:10 am Q3 2021 Earnings Release
2021-09-23 05:25 pm Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00


-15,1
-24,3
37.94%		-30,5
-30,5
-0.02%		0,00
-40,7
-
-46,3

EBIT
Million USD		Released
Forecast
Spread 		0,00


-15,1
-17,8
15.33%		-30,6
-30,7
0.47%		-41,2
-41,1
-0.42%
-46,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-9,20
-16,3
43.37%		-22,5
-15,2
-48.17%		-35,6
-35,0
-1.82%
-40,8

Net income
Million USD		Released
Forecast
Spread 		-0,45


-9,20
-15,6
41.14%		-22,5
-14,8
-52.11%		-35,6
-35,2
-1.16%
-42,8

EPS
USD		Released
Forecast
Spread 		-0,02


-0,21
-0,34
37.94%		-0,43
-0,28
-52.47%		-0,68
-0,67
-0.89%
-0,79

Announcement Date04/06/2128/03/2202/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00




EBITDA
Million USD		Released
Forecast
Spread 		-6,61
-15,8
58.15%		-8,00
-8,90
10.17%		-6,74
-8,80
23.42%		-6,61
-9,65
31.46%		-9,16
-9,20
0.45%		-10,3
-9,35
-10.61%		-9,85
-10,6
6.68%		-9,64
-10,7
9.49%
-10,9

-11,4
-10,9
-5.03%
-11,4


-11,6


-12,0




EBIT
Million USD		Released
Forecast
Spread 		-6,62
-9,33
29.06%		-8,01
-8,00
-0.08%		-6,75
-9,10
25.82%		-6,63
-9,61
31.05%		-9,17
-9,32
1.6%		-10,4
-11,4
8.92%		-9,93
-13,8
28.08%		-9,72
-10,7
9.17%		-11,2
-11,0
-1.68%		-11,5
-11,9
2.72%
-11,7


-11,8


-11,5




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,09
-11,2
63.31%		-5,76
-7,90
27.05%		0,33
-9,06
103.69%		-0,44
-9,57
95.39%		-16,6
-9,28
-78.71%		-10,9
-11,4
4.23%		-7,73
-13,8
43.89%		-5,65
-10,4
45.55%		-11,3
-10,7
-5.84%		-7,67
-11,5
33.19%
-11,3


-11,2


-10,7




Net income
Million USD		Released
Forecast
Spread 		-4,09
-11,2
63.31%		-5,76
-7,90
27.05%		0,33
-9,06
103.69%		-0,44
-9,57
95.39%		-16,6
-9,28
-78.71%		-10,9
-11,4
4.23%		-7,73
-13,8
43.89%		-5,65
-10,4
45.55%		-11,3
-10,7
-5.84%		-7,67
-11,5
33.19%
-11,3


-11,2


-10,7




EPS
USD		Released
Forecast
Spread 		-0,09
-0,20
57%		-0,11
-0,17
32.73%		0,01
-0,17
103.46%		-0,01
-0,17
95.38%		-0,32
-0,17
-89.51%		-0,21
-0,22
2.78%		-0,15
-0,25
40.94%		-0,11
-0,20
45%		-0,21
-0,20
-2.94%		-0,15
-0,22
31.82%
-0,22


-0,22


-0,21


-0,21

Announcement Date28/03/2218/05/2223/08/2210/11/2202/03/2311/05/2323/08/2309/11/2329/02/2403/05/24----

Upcoming sector events for GH Research PLC

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for GH Research PLC

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GHRS Stock
  4. Calendar GH Research PLC
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW